Investor Profile

AndréMouton

Global business developer and strategic equity partner with 25+ years building markets across Southeast Asia, Africa, and the Americas.

25+ Years BD Experience Healthcare & MedTech Southeast Asia · Africa Cross-Border Investment
View Portfolio Connect
25+
Years Experience
10+
Countries Served
3×
Revenue Growth
500+
Global Network
Overview

Seasoned International
Business Developer

André Mouton is a seasoned international business development executive with over 25 years of experience introducing medical products and healthcare solutions to emerging and frontier markets.

His career spans South Africa, Indonesia, Singapore, and the United States — building a deeply rooted global network across healthcare, medtech, and financial sectors.

André has a proven track record of doubling market share and tripling device placements for companies expanding into Southeast Asia and Africa. At SANUWAVE Health, he grew active markets from 3 to 10 countries.

Education
BSc Microbiology — Stellenbosch University
MBA Strategy & Marketing — Thames Valley University (1998–1999)
Dubai Singapore Nashville, TN
A man who knows how to join the dots. There is no better, relevant networker on the international stage — especially, but not exclusively, in the healthcare space.
— Tim Mutton, Peer Recommendation
Experience

Career Highlights

Present
Independent Consultant & Equity Partner
Multiple Ventures
Business development advisory and equity stakes across healthcare, sports, and technology ventures globally. Operating across Dubai, Singapore, and Nashville.
2018–22
VP International Sales
SANUWAVE Health
Expanded active markets from 3 to 10 countries and tripled device placements internationally. Focused on Southeast Asia and EMEA growth corridors.
Prior
EVP International Business Development
CashXAI / Xalles Holdings
Led Africa and Asia expansion for a fintech subsidiary. Designed market entry strategy across 8 countries, building channel partnerships and regulatory frameworks.
Earlier
Senior Roles
International SOS · Bristol-Myers Squibb
Designed pivotal healthcare programmes in Singapore. Gained multinational pharmaceutical strategic marketing experience — building the deep network that underpins all current activity.
Equity Portfolio

Current Shareholding

SportCirqls NZ
Sports Technology · SaaS
New Zealand-based SaaS sports platform targeting NZ, Australia & India markets.
Hagimo
Technology / Platform
Technology holding — co-founder equity position in a growing platform business.
Responsible Capitals USA
Investment Advisory
Family office & responsible investment advisory operating in the United States.
HealthMedical Advisory Global
Healthcare Advisory
Cross-border healthcare advisory leveraging André's 25+ year deep sector network.
FaMOFi
Family Office Advisory · JV
Responsible Capitals + Monaco Private Advisory — Switzerland & Singapore family office joint venture offering curated private wealth advisory to ultra-high-net-worth families across three continents.
Clients & Mandates

Advisory Practice

Cross-border business development and strategic advisory across three global trade corridors — connecting capital, capability and distribution.

AFRICA
→
US · Asia
Market access, capital introduction & BD support
US
→
Asia · Africa
Investment structuring, healthcare & tech advisory
ASIA
→
US · Africa
Cross-border growth partnerships & distribution
Client Roster
Shadow Match
Arc Group
3Sixty
Angaros Group
Affluence Group
Code Tantra
Domverse
Seneca Global
Congress Group
Apollo Medskills
Equity Pipeline

Upcoming SPAC Positions

Additional shareholding opportunities in active structuring — minimum estimated equity value $3M–$5M per position.

Structuring
Tech SPAC
Est. Equity Value
$3M – $5M+
A technology-focused Special Purpose Acquisition Company targeting high-growth tech businesses across the Asia-Pacific and emerging market corridors.
  • Sponsor co-equity stake in SPAC structure
  • Target: Tech companies in APAC & emerging markets
  • Leverages André's Singapore & India BD network
  • Pipeline of acquisition-ready targets identified
Structuring
Health SPAC
Est. Equity Value
$3M – $5M+
A healthcare and medtech SPAC designed to consolidate high-potential healthcare assets across Southeast Asia, Africa, and the Middle East.
  • Sponsor co-equity stake in SPAC structure
  • Target: MedTech, diagnostics, and health services
  • Leverages 25+ years of healthcare BD relationships
  • Regulatory & market entry expertise integrated into thesis
Get in Touch

Let's Connect

Global Business Developer · Strategic Networker · Equity Partner

◉ Dubai, UAE ◉ Singapore ◉ Nashville, TN
LinkedIn Profile

Enquiries by referral and introduction only · All discussions strictly confidential